New treatment option for Breast Cancer
Official title Positron Emission Mammography and Liquid Biopsy in Women With High-risk Breast Screenings
ClinicalTrials.gov ID: NCT06268405
What this study is testing
What is Liquid Biopsy?
Liquid Biopsy is an investigational medicine, being studied as a potential treatment for breast cancer.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The goal of this research study is to evaluate the performance of two experimental tests, namely Liquid Biopsy and Positron Emission Mammography (PEM) in women at high risk of breast cancer. The plan for this study is to assess whether findings from the combination or each individual test can assist radiologists in visualizing and characterizing beast abnormalities.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only
You may be able to join if
- Individuals who are older than 18 years of age
- Individuals who are planned to undergo an MRI-guided biopsy based on high- risk screening imaging detected lesions
- Individuals with the ability to understand and the willingness to sign a written informed consent document
You likely can't join if
- High-risk Individuals with screening-imaging studies without suspicious lesions detected by the standard of care mammogram and/or MRI
- Individuals who are pregnant or who think they may be pregnant
- Individuals who are breast-feeding
- Individuals with known allergies to F-18 FDG
The study team makes the final eligibility decision.
Where it's taking place
- Toronto, Ontario, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Toronto, Ontario, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.